BP-5-087
BP-5-087 is a STAT3 inhibitor used in chronic myeloid leukemia (CML) research. It is investigated in vitro and in vivo to overcome kinase-independent resistance when combined with BCR-ABL1 targeted therapies, addressing a key challenge in CML treatment.
Product Specifications
CAS Number
1803281-30-2
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Smiles
N (CC1=CC=C (C=C1) C2CCCCC2) (C (CN (CC3=C (F) C (F) =C (F) C (F) =C3F) S (=O) (=O) C4=CC=C (C (F) (F) F) C=C4) =O) C5=CC (O) =C (C (O) =O) C=C5
Molecular Formula
C36H30F8N2O6S
Molecular Weight
770.69
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C7910-16D-PE 200 µL
CKBB, NT (Creatine Kinase B-type, Creatine Kinase B Chain, B-CK, CKB) (PE) discontinued
Sign In for Pricing
View Details 
MA3842-.1 100 µL
Anti-Myelin Protein Zero Rabbit Monoclonal Antibody
Sign In for Pricing
View Details OM619236 96 Strip Well
Bovine Heterogeneous Nuclear Ribonucleoprotein A1 ELISA Kit
Sign In for Pricing
View Details 